Yakira Capital Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Yakira Capital Management’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-246,884	Closed	-$2.68K	–	222
2025 Q1	$2.68K	Hold	246,884	–	–	﹤0.01%	187
2024 Q4	$1.73K	Hold	246,884	–	–	﹤0.01%	222
2024 Q3	$3.7K	Hold	246,884	–	–	﹤0.01%	214
2024 Q2	$4.94K	Hold	246,884	–	–	﹤0.01%	216
2024 Q1	$6.54K	Hold	246,884	–	–	﹤0.01%	233
2023 Q4	$2.62K	Hold	246,884	–	–	﹤0.01%	277
2023 Q3	$4.17K	Hold	246,884	–	–	﹤0.01%	297
2023 Q2	$4.39K	Hold	246,884	–	–	﹤0.01%	294
2023 Q1	$4K	Hold	246,884	–	–	﹤0.01%	331
2022 Q4	$3.23K	Hold	246,884	–	–	﹤0.01%	330
2022 Q3	$13K	Hold	246,884	–	–	﹤0.01%	344
2022 Q2	$20K	Hold	246,884	–	–	﹤0.01%	326
2022 Q1	$32K	Sell	246,884 -20,001	-7%	-$5.11K	﹤0.01%	378
2021 Q4	$181K	Hold	266,885	–	–	0.02%	303
2021 Q3	$166K	Hold	266,885	–	–	0.03%	283
2021 Q2	$171K	Hold	266,885	–	–	0.03%	276
2021 Q1	$139K	Hold	266,885	–	–	0.03%	266
2020 Q4	$238K	Buy	+266,885	New	+$182K	0.06%	198

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Yakira Capital Management's REVBW Position: Q2 2025 in Review

Yakira Capital Management sold out of Revelation Biosciences Warrant (REVBW) in Q2 2025, closing a stake of 246,884 shares — an estimated $2.68K sold.

Yakira Capital Management first reported a position in REVBW in Q4 2020 and held it in 18 quarters. The position peaked at $238K in Q4 2020. 12 funds tracked by Wall St. Rank hold REVBW as of Q2 2025.

Yakira Capital Management reported no remaining Revelation Biosciences Warrant position as of Q2 2025 after selling out during the quarter.
Yakira Capital Management sold 246,884 Revelation Biosciences Warrant shares in Q2 2025, an estimated $2.68K.
Yakira Capital Management first reported a position in Revelation Biosciences Warrant in Q4 2020 and held it in 18 quarters.
Yakira Capital Management's Revelation Biosciences Warrant position peaked at $238K in Q4 2020.
12 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2025.

Based on Yakira Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.